BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ismail M, Du Y, Ling L, Li X. Artesunate-heparin conjugate based nanocapsules with improved pharmacokinetics to combat malaria. International Journal of Pharmaceutics 2019;562:162-71. [DOI: 10.1016/j.ijpharm.2019.03.031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Rajwar TK, Pradhan D, Halder J, Rai VK, Kar B, Ghosh G, Rath G. Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review. J Drug Target 2023;:1-15. [PMID: 36604804 DOI: 10.1080/1061186X.2022.2164290] [Reference Citation Analysis]
2 Chaves JB, Portugal Tavares de Moraes B, Regina Ferrarini S, Noé da Fonseca F, Silva AR, Gonçalves-de-albuquerque CF. Potential of nanoformulations in malaria treatment. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.999300] [Reference Citation Analysis]
3 Parikh K, Kapadia R, Pai R, Prajapati M, Shevalkar G. Emerging Formulation Technologies Against Malaria Resurgence. Drug Development for Malaria 2022. [DOI: 10.1002/9783527830589.ch3] [Reference Citation Analysis]
4 Ruwizhi N, Maseko RB, Aderibigbe BA. Recent Advances in the Therapeutic Efficacy of Artesunate. Pharmaceutics 2022;14:504. [DOI: 10.3390/pharmaceutics14030504] [Reference Citation Analysis]
5 Zeng S, Wang H, Tao L, Ning X, Fan Y, Zhao S, Qin L, Chen X. Decoquinate liposomes: highly effective clearance of Plasmodium parasites causing severe malaria. Malar J 2022;21:24. [PMID: 35073922 DOI: 10.1186/s12936-022-04042-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Arredondo-ochoa T, Silva-martínez GA. Microemulsion Based Nanostructures for Drug Delivery. Front Nanotechnol 2022;3:753947. [DOI: 10.3389/fnano.2021.753947] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tijjani H, Zangoma MH, Olatunde A, Abdullahi A, Egbuna C, Danyaro AM. Nanotechnology application for effective delivery of antimalarial drugs. Applications of Nanotechnology in Drug Discovery and Delivery 2022. [DOI: 10.1016/b978-0-12-824408-1.00006-5] [Reference Citation Analysis]
8 Halder U, Biswas R, Kabiraj A, Majhi K, Let M, Bandopadhyay R. Recent patents and current emergence of polysaccharides- based nanoparticles in medicine and drug delivery. Polysaccharide Nanoparticles 2022. [DOI: 10.1016/b978-0-12-822351-2.00007-3] [Reference Citation Analysis]
9 Patra S, Singh M, Wasnik K, Pareek D, Gupta PS, Mukherjee S, Paik P. Polymeric Nanoparticle Based Diagnosis and Nanomedicine for Treatment and Development of Vaccines for Cerebral Malaria: A Review on Recent Advancement. ACS Appl Bio Mater 2021;4:7342-65. [PMID: 35006689 DOI: 10.1021/acsabm.1c00635] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
10 Banik N, Yang SB, Kang TB, Lim JH, Park J. Heparin and Its Derivatives: Challenges and Advances in Therapeutic Biomolecules. Int J Mol Sci 2021;22:10524. [PMID: 34638867 DOI: 10.3390/ijms221910524] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
11 Anamika J, Nikhar V, Laxmikant G, Priya S, Sonal V, Vyas SP. Nanobiotechnological modules as molecular target tracker for the treatment and prevention of malaria: options and opportunity. Drug Deliv Transl Res 2020;10:1095-110. [PMID: 32378173 DOI: 10.1007/s13346-020-00770-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
12 Koi H, Takahashi N, Fuchi Y, Umeno T, Muramatsu Y, Seimiya H, Karasawa S, Oguri H. A fully synthetic 6-aza-artemisinin bearing an amphiphilic chain generates aggregates and exhibits anti-cancer activities. Org Biomol Chem 2020;18:5339-43. [PMID: 32618320 DOI: 10.1039/d0ob00919a] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
13 Rashidzadeh H, Tabatabaei Rezaei SJ, Adyani SM, Abazari M, Rahamooz Haghighi S, Abdollahi H, Ramazani A. Recent advances in targeting malaria with nanotechnology-based drug carriers. Pharm Dev Technol 2021;26:807-23. [PMID: 34190000 DOI: 10.1080/10837450.2021.1948568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Gatadi S, Madhavi Y, Nanduri S. Nanoparticle drug conjugates treating microbial and viral infections: A review. Journal of Molecular Structure 2021;1228:129750. [DOI: 10.1016/j.molstruc.2020.129750] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
15 Zhang J, Zuo T, Yang J, Hu Z, Wang Z, Xu R, Ma S, Wei Y, Shen Q. Hierarchically Releasing Bio-Responsive Nanoparticles for Complete Tumor Microenvironment Modulation via TGF-β Pathway Inhibition and TAF Reduction. ACS Appl Mater Interfaces 2021;13:2256-68. [PMID: 33423468 DOI: 10.1021/acsami.0c18545] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ke Y, Cui L, Ma Z, Xu X, Chen R, Lan X, Shi Q, Yin J. Inhibition of cancer-associated thrombosis with redox-sensitive paclitaxel/heparin-deoxycholic acid nanoparticles. Colloid and Interface Science Communications 2021;40:100345. [DOI: 10.1016/j.colcom.2020.100345] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Alven S, Aderibigbe B. Nanoformulations of old and new antimalarial drugs. Applications of Nanobiotechnology for Neglected Tropical Diseases 2021. [DOI: 10.1016/b978-0-12-821100-7.00010-8] [Reference Citation Analysis]
18 Lyu HN, Ma N, Meng Y, Zhang X, Wong YK, Xu C, Liao F, Jiang T, Tu Y, Wang J. Study towards improving artemisinin-based combination therapies. Nat Prod Rep 2021;38:1243-50. [PMID: 34287440 DOI: 10.1039/d0np00079e] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
19 Guo H, Abbasi YF, Bera H, Yang M. Biopolymer–drug conjugates as biomaterials. Tailor-Made and Functionalized Biopolymer Systems 2021. [DOI: 10.1016/b978-0-12-821437-4.00019-0] [Reference Citation Analysis]
20 Wang X, Xie Y, Jiang N, Wang J, Liang H, Liu D, Yang N, Sang X, Feng Y, Chen R, Chen Q. Enhanced Antimalarial Efficacy Obtained by Targeted Delivery of Artemisinin in Heparin-Coated Magnetic Hollow Mesoporous Nanoparticles. ACS Appl Mater Interfaces 2021;13:287-97. [PMID: 33356111 DOI: 10.1021/acsami.0c20070] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ansari MA, Badrealam KF, Alam A, Tufail S, Khalique G, Equbal MJ, Alzohairy MA, Almatroudi A, Alomary MN, Pottoo FH. Recent Nano-based Therapeutic Intervention of Bioactive Sesquiterpenes: Prospects in Cancer Therapeutics. Curr Pharm Des 2020;26:1138-44. [PMID: 31951164 DOI: 10.2174/1381612826666200116151522] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
22 Jokonya S, Langlais M, Leshabane M, Reader PW, Vosloo JA, Pfukwa R, Coertzen D, Birkholtz LM, Rautenbach M, Klumperman B. Poly(N-vinylpyrrolidone) Antimalaria Conjugates of Membrane-Disruptive Peptides. Biomacromolecules 2020;21:5053-66. [PMID: 33156615 DOI: 10.1021/acs.biomac.0c01202] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
23 Karabasz A, Bzowska M, Szczepanowicz K. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature. Int J Nanomedicine 2020;15:8673-96. [PMID: 33192061 DOI: 10.2147/IJN.S231477] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 8.3] [Reference Citation Analysis]
24 Zhang J, Yang J, Zuo T, Ma S, Xokrat N, Hu Z, Wang Z, Xu R, Wei Y, Shen Q. Heparanase-driven sequential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast cancer therapy. Biomaterials 2021;266:120429. [PMID: 33035717 DOI: 10.1016/j.biomaterials.2020.120429] [Cited by in Crossref: 41] [Cited by in F6Publishing: 53] [Article Influence: 13.7] [Reference Citation Analysis]
25 Szafraniec-Szczęsny J, Janik-Hazuka M, Odrobińska J, Zapotoczny S. Polymer Capsules with Hydrophobic Liquid Cores as Functional Nanocarriers. Polymers (Basel) 2020;12:E1999. [PMID: 32887444 DOI: 10.3390/polym12091999] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
26 Lantero E, Aláez-Versón CR, Romero P, Sierra T, Fernàndez-Busquets X. Repurposing Heparin as Antimalarial: Evaluation of Multiple Modifications Toward In Vivo Application. Pharmaceutics 2020;12:E825. [PMID: 32872434 DOI: 10.3390/pharmaceutics12090825] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Deng S, Gigliobianco MR, Censi R, Di Martino P. Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities. Nanomaterials (Basel) 2020;10:E847. [PMID: 32354008 DOI: 10.3390/nano10050847] [Cited by in Crossref: 78] [Cited by in F6Publishing: 88] [Article Influence: 26.0] [Reference Citation Analysis]
28 Hao DL, Xie R, De GJ, Yi H, Zang C, Yang MY, Liu L, Ma H, Cai WY, Zhao QH, Sui F, Chen YJ. pH-Responsive Artesunate Polymer Prodrugs with Enhanced Ablation Effect on Rodent Xenograft Colon Cancer. Int J Nanomedicine 2020;15:1771-86. [PMID: 32214810 DOI: 10.2147/IJN.S242032] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]